Search Results 1271-1280 of 13925 for Assay
Planned use of other commercially available or investigational cfDNA or gene expression profile assays for rejection surveillance. Pregnant. Hemodynamically ...
Qualifying deleterious SPOP mutation detected on any archival genomic assay (tissue and/or liquid biopsy) is acceptable for study inclusion. Qualifying ...
The purpose of this study is to validate the use of a RNAseq-based peripheral blood assay in liver transplant recipients when correlated to liver biopsy results ...
Clinical Biochemistry & Immunology provides analysis of biological fluids or tissues for specific chemical constituents or physiologic processes.
... assay validations. You will benefit from the supervision of three dedicated microbiology medical directors, who rotate service coverage and will partner ...
HbA1C > % (75 mmol/mol), as assessed using NGSP certified method and standardized to DCCT assay. Fasting Plasma Glucose > 270 mg/dL (15 mmol/L). Fasting ...
Studies comparing HCV RNA assays are not considered exclusionary. Participating Mayo Clinic locations. Study statuses change often. Please contact the study ...
... assay (e.g., Abbott, Hybritech); Baseline PSA must not be obtained during any of the following time frames:10-day period after prostate biopsy, after ...
ctDNA assay must be performed through this trial or study BNT000-001 ctDNA screening protocol. * Patients must have an Eastern Cooperative Oncology Group ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.